Categories

A sample text widget

Etiam pulvinar consectetur dolor sed malesuada. Ut convallis euismod dolor nec pretium. Nunc ut tristique massa.

Nam sodales mi vitae dolor ullamcorper et vulputate enim accumsan. Morbi orci magna, tincidunt vitae molestie nec, molestie at mi. Nulla nulla lorem, suscipit in posuere in, interdum non magna.

Making money out of obesity & diabetes

The pharmaceutical companies have come up with Rimonabant that will control appetite weight and perhaps inhibit smoking.

The food company Nestlé comes up with a cereal bar that will inhibit obesity and diabetes. There is money in flab and this is the most promising basis for assuming a discovery will be made which limits the world epidemic of obesity and diabetes.

At the company’s mountainside research laboratory… scientists are working on new products that alter the body’s absorption of sugar, reduce fatty acids in the bloodstream, and step up the burning of carbohydrates during digestion. The first of these offerings, a cereal bar with a fiber additive that tamps down surges in blood sugar levels after eating, was launched in Asia last year and will soon be rolled out worldwide.

For now, the cereal bar is marketed mainly to people with type 2 diabetes, which is often triggered by obesity. But Nestlé says the same additive could later find its way into mass-market brands such as Stouffer’s and Lean Cuisine prepared meals. And with more than 300 million obese people worldwide, including 30% of U.S. adults, it’s easy to understand Nestlé’s interest in the market.

Thanks John Shannon.

Comments are closed.